USPTO serial 88979967
PAPA & BARKLEY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SALES, HEATHER ALISON
- Law office
- TMO LAW OFFICE 130 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PAPA & BARKLEY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas F. Zuber
Thomas F. Zuber ZUBER LAWLER LLP350 S. GRAND AVE., 32ND FLOORLOS ANGELES, CA 90071UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Essential oils for cosmetic purposes, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Cosmetics, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Cosmetics, namely, non-medicated body oils, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Cosmetics, namely, non-medicated body ointments, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Cosmetics, namely, non-medicated body ointments in drop form and liquid form, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Non-medicated body soaks, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Electronic cigarette liquid (e-liquid) comprised of essential oils, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others | ACTIVE | — |
| 005 | Mentholated ointment for medical use, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Medicated skin oils, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Topical analgesics, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Analgesic balm, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Medicated skin creams and lotions, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; medicated skin care preparations, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; medicated herbal topical creams, gels, skin sprays, balms, liniment and ointments, all for the relief of pain, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Topical gel for medical and therapeutic treatment of minor aches and pains of muscles and joints, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Herbal tinctures for medical purposes, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Medicated oral spray for pain, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Pharmaceutical, medicinal, medicated herbal, medicated botanical, and medicated preparations in the form of salves, concentrates, pastes, extracts, tinctures, and mucous membrane doses, for use in acting upon or caring for pain, muscle tension, muscle spasms, and gastrointestinal illness, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others; Muscle soaks, all the foregoing containing only federally-lawful materials such as lavender, mint, cardamom, ginger, myrrh, and spearmint, among others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 3, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 3, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 15, 2022 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Apr 15, 2022 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Apr 15, 2022 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Oct 23, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 22, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 22, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 26, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 10, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 10, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 10, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 24, 2020 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 23, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Dec 15, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 15, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 15, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 14, 2020 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Dec 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 14, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 14, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 14, 2020 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Dec 14, 2020 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Dec 14, 2020 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Dec 14, 2020 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Dec 13, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 13, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 13, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 13, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 11, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| May 11, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 11, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 4, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 29, 2020 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Apr 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2020 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Oct 29, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2019 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 28, 2019 | NWAP | NEW APPLICATION ENTERED | — |